Voltage-Gated Sodium Channel Blockade in Neurological Conditions

Mechanism of Action

The electrical signal from neuronal firing travels down the axon to the presynaptic terminal, triggering neurotransmitter release, according to the British Journal of Pharmacology 1
Fewer action potentials mean less calcium influx through voltage-gated calcium channels at the nerve terminal, as noted in Chest 2
This directly decreases the release of excitatory neurotransmitters into the synaptic cleft, as reported in the British Journal of Pharmacology 1

In chronic pain and potentially bipolar disorder, prolonged neuronal activation sensitizes both presynaptic and postsynaptic neurons, as stated in the British Journal of Pharmacology 1
VGSC blockade interrupts this cycle by limiting presynaptic neurotransmitter release, with VGCC blockade having a distinct mechanism, as described in Chest 2
Unlike levetiracetam, VGSC blockers work by limiting action potential propagation, as noted in Neuropsychopharmacology 3
Carbamazepine induces cytochrome P450 enzymes, leading to decreased blood levels over time and potential drug interactions, according to Neuropsychopharmacology 3
Lamotrigine and other VGSC blockers may cause acute impairment but generally do not result in clinically meaningful driving impairment with chronic administration, as reported in Neuropsychopharmacology 3

Carbamazepine and oxcarbazepine are identified as the preferred voltage‑gated sodium‑channel blockers for stabilizing mood in bipolar disorder, showing dramatic therapeutic responses in clinical studies. 4

Low‑dose regimens are typically sufficient: about 85 % of patients with paroxysmal neurological conditions achieve complete remission when treated with carbamazepine 50–200 mg/day or oxcarbazepine 75–300 mg/day. 4

The mood‑stabilizing benefits of these sodium‑channel blockers can be observed within the first week of initiating therapy. 4